Related Experiment Video
Updated: May 11, 2026

Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
Engineering of bacterial strains and their products for cancer therapy
Nuno Bernardes1, Ananda M Chakrabarty, Arsenio M Fialho
1Institute for Biotechnology and Bioengineering (IBB), Center for Biological and Chemical Engineering, Instituto Superior Técnico, 1049-001, Lisbon, Portugal.
Abstract:
The use of live bacteria in cancer therapies offers exciting possibilities. Nowadays, an increasing number of genetically engineered bacteria are emerging in the field, with applications both in therapy and diagnosis. In parallel, purified bacterial products are also gaining relevance as new classes of bioactive products to treat and prevent cancer growth and metastasis. In the first part of the article, we review the latest findings regarding the use of live bacteria and products as anti-cancer agents, paying special attention to immunotoxins, proteins, and peptides. In particular, we focus on the recent results of using azurin or its derived peptide as anticancer therapeutic agents. In the second part, we discuss the challenges of using metagenomic techniques as a distinctive approach for discovering new anti-cancer agents from bacterial origin.
Related Concept Videos
Bioreactor Controls-III
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Production of Pharmaceuticals
Microorganisms in Medicine and Therapeutics
